PIPIER, Angélique, Titouan CHETOT, Apollonia KALAMATIANOU, Nicolas MARTIN, Maëlle CAROFF, Sébastien BRITTON, Nicolas CHÉRON, Lukáš TRANTÍREK, Anton GRANZHAN and David MONCHAUD. Structural Optimization of Azacryptands for Targeting Three-Way DNA Junctions. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. WEINHEIM: WILEY-V C H VERLAG GMBH, 2024. ISSN 1433-7851. Available from: https://dx.doi.org/10.1002/anie.202409780.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Structural Optimization of Azacryptands for Targeting Three-Way DNA Junctions
Authors PIPIER, Angélique, Titouan CHETOT, Apollonia KALAMATIANOU, Nicolas MARTIN, Maëlle CAROFF, Sébastien BRITTON, Nicolas CHÉRON, Lukáš TRANTÍREK, Anton GRANZHAN and David MONCHAUD.
Edition ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, WEINHEIM, WILEY-V C H VERLAG GMBH, 2024, 1433-7851.
Other information
Type of outcome Article in a journal
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 16.600 in 2022
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1002/anie.202409780
UT WoS 999
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 27/6/2024 09:00.
Abstract
Transient melting of the duplex-DNA (B-DNA) during DNA transactions allows repeated sequences to fold into non-B DNA structures, including DNA junctions and G-quadruplexes. These noncanonical structures can act as impediments to DNA polymerase progression along the duplex, thereby triggering DNA damage and ultimately jeopardizing genomic stability. Their stabilization by ad hoc ligands is currently being explored as a putative anticancer strategy since it might represent an efficient way to inflict toxic DNA damage specifically to rapidly dividing cancer cells. The relevance of this strategy is only emerging for three-way DNA junctions (TWJs) and, to date, no molecule has been recognized as a reference TWJ ligand, featuring both high affinity and selectivity. Herein, we characterize such reference ligands through a combination of in vitro techniques comprising affinity and selectivity assays (competitive FRET-melting and TWJ Screen assays), functional tests (qPCR and Taq stop assays), and structural analyses (molecular dynamics and NMR investigations). We identify novel azacryptands TrisNP-amphi and TrisNP-ana as the most promising ligands, interacting with TWJs with high affinity and selectivity. These ligands represent new molecular tools to investigate the cellular roles of TWJs and explore how they can be exploited in innovative anticancer therapies.
Links
LX22NPO5102, research and development projectName: Národní ústav pro výzkum rakoviny (Acronym: NÚVR)
Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES
PrintDisplayed: 29/7/2024 12:18